The importance of treatment regimens and pubertal status for growth in IBD

Journal of Pediatrics

Volumn 154, Issue 6, 2009, Pages 936-937

  DeBoer, Mark D ^a   Barnes, Barrett H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; INFLIXIMAB; PREDNISONE;

BONE AGE; CHRONOLOGY; ENTERITIS; GROWTH RATE; HUMAN; LETTER; PRIORITY JOURNAL; PUBERTY;

CHILD; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INFLAMMATORY BOWEL DISEASES; PUBERTY; RECOMBINANT PROTEINS;

EID: 65549122900     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.01.044     Document Type: Letter

References (2)

1. Heyman M.B., Garnett E.A., Wojcicki J., Gupta N., Davis C., Cohen S.A., et al. Growth hormone treatment for growth failure in pediatric patients with Crohn's disease. J Pediatr 153 (2008) 651-658
2. Walters T.D., Gilman A.R., and Griffiths A.M. Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease. Inflamm Bowel Dis 13 (2007) 424-430